Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7396 | 1292 | 49.6 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ESTROGEN RECEPTOR BETA | Author keyword | 45 | 26% | 12% | 151 |
2 | ER BETA | Author keyword | 18 | 24% | 5% | 68 |
3 | RECEPTOR BIOL SECT | Address | 13 | 30% | 3% | 36 |
4 | ER BETA ISOFORMS | Author keyword | 8 | 100% | 0% | 5 |
5 | NUCL RECEPTORS CELL SIGNALING | Address | 6 | 17% | 3% | 33 |
6 | REPROD SCI CELLULAR MOL PHARMACOL | Address | 6 | 100% | 0% | 4 |
7 | ER BETA 1 | Author keyword | 5 | 60% | 0% | 6 |
8 | ER BETA 2 | Author keyword | 5 | 63% | 0% | 5 |
9 | ER BETA CX | Author keyword | 4 | 67% | 0% | 4 |
10 | LRP16 | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ESTROGEN RECEPTOR BETA | 45 | 26% | 12% | 151 | Search ESTROGEN+RECEPTOR+BETA | Search ESTROGEN+RECEPTOR+BETA |
2 | ER BETA | 18 | 24% | 5% | 68 | Search ER+BETA | Search ER+BETA |
3 | ER BETA ISOFORMS | 8 | 100% | 0% | 5 | Search ER+BETA+ISOFORMS | Search ER+BETA+ISOFORMS |
4 | ER BETA 1 | 5 | 60% | 0% | 6 | Search ER+BETA+1 | Search ER+BETA+1 |
5 | ER BETA 2 | 5 | 63% | 0% | 5 | Search ER+BETA+2 | Search ER+BETA+2 |
6 | ER BETA CX | 4 | 67% | 0% | 4 | Search ER+BETA+CX | Search ER+BETA+CX |
7 | LRP16 | 4 | 67% | 0% | 4 | Search LRP16 | Search LRP16 |
8 | BETA ERKO | 4 | 75% | 0% | 3 | Search BETA+ERKO | Search BETA+ERKO |
9 | ESTROGEN RECEPTOR BETA 2 | 4 | 75% | 0% | 3 | Search ESTROGEN+RECEPTOR+BETA+2 | Search ESTROGEN+RECEPTOR+BETA+2 |
10 | OESTROGEN RECEPTOR BETA | 4 | 26% | 1% | 12 | Search OESTROGEN+RECEPTOR+BETA | Search OESTROGEN+RECEPTOR+BETA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ER BETA | 87 | 23% | 25% | 326 |
2 | ER ALPHA | 24 | 12% | 15% | 195 |
3 | REPRODUCTIVE PHENOTYPES | 15 | 29% | 3% | 44 |
4 | SP1 COMPLEX | 10 | 63% | 1% | 10 |
5 | ALPHA ER ALPHA | 9 | 24% | 3% | 35 |
6 | ER BETA 1 | 9 | 83% | 0% | 5 |
7 | CATHEPSIN D GENE | 9 | 37% | 1% | 19 |
8 | OVARIAN PHENOTYPE | 8 | 70% | 1% | 7 |
9 | ELEMENT HALF SITE | 8 | 44% | 1% | 14 |
10 | RODENT MAMMARY GLAND | 6 | 71% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Estrogen receptor beta in breast cancer | 2014 | 8 | 55 | 84% |
The different roles of ER subtypes in cancer biology and therapy | 2011 | 147 | 176 | 34% |
DHEA - a precursor of ER beta ligands | 2015 | 2 | 30 | 30% |
Estrogen receptors: How do they signal and what are their targets | 2007 | 547 | 303 | 15% |
Estrogen hormone physiology: Reproductive findings from estrogen receptor mutant mice | 2014 | 8 | 46 | 43% |
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways | 2008 | 122 | 123 | 45% |
Estrogen receptor beta in breast cancer-Diagnostic and therapeutic implications | 2009 | 55 | 96 | 47% |
Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target | 2008 | 46 | 60 | 85% |
Loss of ER beta expression as a common step in estrogen-dependent tumor progression | 2004 | 244 | 124 | 47% |
The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer | 2009 | 77 | 44 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RECEPTOR BIOL SECT | 13 | 30% | 2.8% | 36 |
2 | NUCL RECEPTORS CELL SIGNALING | 6 | 17% | 2.6% | 33 |
3 | REPROD SCI CELLULAR MOL PHARMACOL | 6 | 100% | 0.3% | 4 |
4 | DIGEST VASC | 3 | 50% | 0.4% | 5 |
5 | MED NUTR BIOSCI | 3 | 33% | 0.6% | 8 |
6 | ENVIRONM HLTH MED | 2 | 67% | 0.2% | 2 |
7 | SCI ENGN 3013 | 2 | 67% | 0.2% | 2 |
8 | TAMU 4466 | 2 | 67% | 0.2% | 2 |
9 | MOL MED GENOM | 2 | 24% | 0.5% | 6 |
10 | ENVIRONM GENET MOL TOXICOL | 2 | 17% | 0.7% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000295772 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |
2 | 0.0000247762 | SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS |
3 | 0.0000184060 | EFFERENT DUCTULES//BIOCHIM IRBA//UP EA 2608 |
4 | 0.0000167215 | ESTROGEN RECEPTOR ALPHA GENE ESR1//ESTROGEN RECEPTOR POLYMORPHISMS//ESTROGEN RECEPTOR 1 |
5 | 0.0000166851 | JIANGDA PATHOL//APOPTOTIC EFFECTS//BETA CX |
6 | 0.0000146727 | GPR30//GPER//PELP1 |
7 | 0.0000143291 | AIB1//STEROID HORMONES SECT//RIP140 |
8 | 0.0000089210 | PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A |
9 | 0.0000069467 | AROMATASE DEFICIENCY//MALE OSTEOPOROSIS//INTEGRATED MED ENDOCRINOL METAB GERIATR |
10 | 0.0000065436 | CRLC OSCAR LAMBRET//UKRAINIAN ONCOL RADIOL//6 METHYL 1 3 8 TRICHLORODIBENZOFURAN |